Bradley Stevens, PA
Surgical · Salt Lake City, UTNPI 1396283248
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Vericel Corporation at 31.9% of the total. Reporting peaked in 2022 at $230 and has fallen 62.7% since, to $86 in 2025.
Across 19 payments — averaging $20.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vericel Corporation$124
- Johnson & Johnson$69
- Heron Therapeutics, Inc.$68
- Bioventus LLC$36
- Ferring Pharmaceuticals Inc.$27
- SPR Therapeutics, Inc$18
- plus $47 from 3 others
What the payments were for
- Food & beverage$390100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vericel Corporation | 5 | $124 |
| Johnson & Johnson(2 entities) | 3 | $69 |
| Heron Therapeutics, Inc. | 3 | $68 |
| Bioventus LLC | 2 | $36 |
| Ferring Pharmaceuticals Inc. | 2 | $27 |
| SPR Therapeutics, Inc | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $17 |
| Heraeus Medical, LLC. | 1 | $17 |
| Davol Inc. | 1 | $14 |
How this compares
$390 in reported general payments places this provider in the 55th percentile of 121 surgical providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 31 | $307 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 34 | $285 |
| Cyclobenzaprine Hcl | 54 | $261 |
| Ibuprofen | 28 | $254 |
| Tramadol Hcl | 39 | $229 |
| Diclofenac Sodium | 18 | $203 |
| Celecoxib | 17 | $180 |
| Promethazine Hcl | 39 | $175 |
| Oxycodone Hcl | 22 | $96 |
Paid to pharmacies, not to this prescriber.
Other surgical in Salt Lake City
- Scott HadfieldSalt Lake City$10K
- Brittany CrossSalt Lake City$6K
- Brittney TaylorSalt Lake City$4K
- Meagan ThomasSalt Lake City$3K
- Jessica WoeppelSalt Lake City$2K
- Danielle ChristensenSalt Lake City$2K
- Jennifer StrumoloSalt Lake City$2K
- Heather GeorgeSalt Lake City$2K
- Cristina BerkholderSalt Lake City$1K
- Meghan CalamelSalt Lake City$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.